How long until chlamydia or gonorrhea clears after treatment?
Part of Infections clinical trials.
This study follows people with chlamydia or gonorrhea after they receive standard treatment to see how long it takes for the infection to clear from the body. It helps doctors understand when it's safe to assume you are no longer contagious.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have a chlamydia and/or gonorrhea infection that is not complicated (not affecting other parts of the body like the testicles, joints, or eyes)
- You have received the standard recommended treatment for your infection
- You are getting care at the Trait d'Union department at the Nouvel Hôpital Civil in Strasbourg for PrEP, HIV, or accidental exposure to HIV
- You are not severely immunocompromised (e.g., HIV with very low CD4 count, recent chemotherapy, or long-term high-dose steroids)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of medications (doxycycline, pentoxifylline, and nitazoxanide) in men with untreated gonorrhea and chlamydia. It may help clear the infection more effectively, but you must meet specific safety and health criteria.
This study examines how your body's immune system responds to a Chlamydia trachomatis infection by analyzing urine and blood samples. Researchers hope to better understand infection patterns and improve future treatments.
This trial compares two ways of testing for chlamydia and gonorrhea in people who don't have symptoms. It aims to see if faster, point-of-care testing improves outcomes compared to standard lab testing.
This trial tests whether a 7-day course of doxycycline is effective for treating an anal chlamydia infection (lymphogranuloma venereum) in people who do not have symptoms. Participants will take the antibiotic for a week and be followed for four weeks.
This study looks at how a single 200 mg dose of doxycycline works in the body to prevent bacterial sexually transmitted infections (like chlamydia, gonorrhea, and syphilis) after a risky sexual encounter. It is for men who have sex with men and are already on PrEP or living with HIV.
This study tests whether taking a daily antibiotic (doxycycline) can prevent sexually transmitted infections in people at high risk. If you've had an STI recently and sometimes have sex without condoms, you might be able to join.
Hear when a new Chlamydia Trachomatis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.